Dapagliflozin Audit ADA San Diego, June 11 2017b - Poster

Lack of risk factors predicting the development of genital mycotic infections among patients treated with dapagliflozin: the ABCD Nationwide Dapagliflozin Audit

KY Thong¹, M Yadagiri², P Tong³, D Barnes⁴, D Morris⁵, T Chowdhury⁶, LL Chuah⁷, M Cohen⁸, A Kennedy⁹, T Robinson¹⁰, SC Bain¹¹, KA Adamson¹², REJ Ryder² , ABCD Nationwide Dapagliflozin Audit contributors

¹University of Western Australia, Perth, Australia

²City Hospital, Birmingham, UK

³Qualigenics Medical, Central, Hong Kong

⁴The Tunbridge Wells Hospital, Pembury, UK 

⁵Northgate Heatlh Centre, Shropshire UK

⁶The Royal London Hospital, London, UK,

⁷Croydon Health Services NHS Trust, Croydon, UK

⁸Barnet Hospital, Barnet, UK

⁹Antrim Area Hospital, Antrim, UK

¹⁰Royal United Hospitals, Bath, UK 

¹¹Abertawe Bro Morgannwyg University Board, Swansea, UK

¹²St John’s Hospital, Livingston, UK